Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Vitrolife Logo
Vitrolife Growth Score
86
CB Rank
69996
Heat Score
74
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
Founded
obfuscation
PublicPost-IPO Debt Frölunda, Vastra Gotaland, Sweden1001-5000 www.vitrolife.com/
Biotechnology
Health Care
Therapeutics
Overview

Vitrolife
Total Funding
obfuscation
Growth Score
86
Heat Score
74

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score86
0 pts
in past quarter
Heat Score 74
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Vitrolife

CB Rank
69996
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
Founded
obfuscation
PublicPost-IPO Debt Frölunda, Vastra Gotaland, Sweden1001-5000 www.vitrolife.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation

Key People

  • Photo of David O'Rourke
    David O'Rourke: Advanced Clincal Embryology Support & Education
    Past Role: Merck, Fertility Technologies Embryologist UK and Ireland
  • Photo of Karen Sörensen
    Karen Sörensen: Non Executive Board Member
    Past Role: Philips Healthcare, CEO Nordic

Details

Legal Name Vitrolife Sweden AB
Operating Status Active
Stock Symbol  STO:VITR
Company Type For Profit
About the Company

Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. The company also develops various media that enable researchers and cell therapy companies to use cells for therapeutic purposes.

Vitrolife was founded in 1994 and is based in Frolunda, Sweden with subsidiaries in USA, Hungary, Australia, France,

Italy, United Kingdom, and Japan

Phone Number +46 31 721 81 00
Contact Email fertility@vitrolife.com
Predictions & Insights

Growth Insight

See this Growth Insight
Vitrolife is
Lorem
 to be growing
Top Contributing Factors
Financial Decline

Products & Services

EmbryoGlue
A hyaluronan-enriched embryo transfer medium designed to support implantation and improve pregnancy outcomes.
EmbryoScope+ Time-Lapse System
A time-lapse imaging system for continuous monitoring and evaluation of embryo development in IVF laboratories.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Vitrolife Logo
Post-IPO Debt - Vitrolife
3
obfuscation
— Post-IPO Debt

Investors

Investments

Number of Acquisitions 7

Investment Breakdown

Number of Acquisitions 7
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 5 Contacts 248

Employee Profiles

News

News and Press

News•Jun 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

11,514
19.56%
 in past month

IT Spend

$24.8MThis year, Vitrolife is projected to spend $24.8M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Helium-free MRI (Magnetic Resonance Imaging) Logo
Helium-free MRI (Magnetic Resonance Imaging)
100
Yelp Logo
Yelp
93
Endovascular Robotics Logo
Endovascular Robotics
93

Actively Used Products

21Vitrolife uses 21 technology products and services including HTML5, DigiCert, and  Cloudflare CDN, according to G2 Stack.

Active Website Tech Count

44Vitrolife is actively using 44 technologies for its website, according to BuiltWith. These include DNSSEC, LetsEncrypt, and  Font Awesome.

Total IP

38The intellectual property of Vitrolife includes 12 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Vitrolife has registered 26 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
Igenomix Logo
IgenomixSubsidiary
Frequently Asked Questions

Where is Vitrolife's headquarters? Vitrolife is located in Frölunda, Vastra Gotaland, Sweden.Who invested in Vitrolife? Vitrolife has 3 investors including SEB (Skandinaviska Enskilda Banken) and  Nordea.When was the last funding round for Vitrolife? Vitrolife closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Vitrolife's competitors? Alternatives and possible competitors to Vitrolife may include Embie, eIVF, and  CooperSurgical Fertility Solutions.How much funding has Vitrolife raised to date? Vitrolife has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8c8a01a 1)
|